Virtu Financial LLC Idera Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.38 - $0.53 $7,864 - $10,969	20,697 Added 70.93%	49,876 $19,000
Q2 2022 Aug 09, 2022	SELL	$0.32 - $0.74 $5,500 - $12,719	-17,189 Reduced 37.07%	29,179 $13,000
Q1 2022 May 17, 2022	BUY	$0.41 - $0.7 $19,010 - $32,457	46,368 New	46,368 $23,000
Q3 2021 Nov 12, 2021	SELL	$1.0 - $1.18 $325,330 - $383,889	-325,330 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$1.01 - $1.58 $179,858 - $281,363	178,078 Added 120.93%	325,330 $390,000
Q1 2021 May 19, 2021	BUY	$1.23 - $5.98 $181,119 - $880,566	147,252 New	147,252 $191,000
Q2 2020 Aug 07, 2020	SELL	$1.23 - $2.12 $27,106 - $46,720	-22,038 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.45 - $2.79 $31,955 - $61,486	22,038 New	22,038 $40,000
Q1 2019 Apr 12, 2019	SELL	$2.33 - $3.79 $27,780 - $45,188	-11,923 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$2.77 - $9.38 $33,026 - $111,837	11,923 New	11,923 $33,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.